Unique ID issued by UMIN | UMIN000038155 |
---|---|
Receipt number | R000043498 |
Scientific Title | Comparison on the prevention of household influenza infection between baloxavir marboxil and neuraminidase inhibitors using health insurance claims database -2018/2019 influenza season- |
Date of disclosure of the study information | 2019/10/01 |
Last modified on | 2021/01/20 15:55:29 |
Comparison on the prevention of household influenza infection between baloxavir marboxil and neuraminidase inhibitors using health insurance claims database -2018/2019 influenza season-
Comparison on the prevention of household influenza infection between baloxavir marboxil and neuraminidase inhibitors using health insurance claims database
Comparison on the prevention of household influenza infection between baloxavir marboxil and neuraminidase inhibitors using health insurance claims database -2018/2019 influenza season-
Comparison on the prevention of household influenza infection between baloxavir marboxil and neuraminidase inhibitors using health insurance claims database
Japan |
Influenza virus infection
Infectious disease |
Others
NO
To examine the preventive effect of baloxavir marboxil on household influenza infection compared with neuraminidase inhibitors in 2018/2019 influenza season. The primary comparison drug is oseltamivir.
Efficacy
Occurrence of household influenza infection
Observational
Not applicable |
Not applicable |
Male and Female
1)Families which had an IC (index case; the first patient diagnosed as influenza in each family) during the enrollment period (1 Oct 2018 - 23 Apr 2019)
2)Families whose IC was an outpatient
3)Families whose IC received baloxavir marboxil, oseltamivir, zanamivir or laninamivir on Day 1 (the first date when an IC was diagnosed as influenza).
1)Families in which no family member was identified other than the IC
2)Families which had two or more ICs
3)Families whose IC was hospitalized after outpatient diagnosis
4)Families whose IC received several anti-influenza drugs
120000
1st name | Masaru |
Middle name | |
Last name | Sawada |
Shionogi & Co., Ltd.
Pharmacovigilance Department
541-0045
1-8, Doshomachi 3-Chome, Chuo-ku, Osaka 541-0045, Japan
+81-6-6209-6974
masaru.sawada@shionogi.co.jp
1st name | Masakazu |
Middle name | |
Last name | Notohara |
Shionogi & Co., Ltd.
Pharmacovigilance Department
541-0045
1-8, Doshomachi 3-Chome, Chuo-ku, Osaka 541-0045, Japan
+81-6-6209-6958
masakazu.notohara@shionogi.co.jp
Shionogi & Co., Ltd.
Shionogi & Co., Ltd.
Profit organization
N/A
N/A
N/A
N/A
NO
2019 | Year | 10 | Month | 01 | Day |
Published
https://academic.oup.com/cid/advance-article-abstract/doi/10.1093/cid/ciaa1622/5939856
208225
please refer described below:
https://academic.oup.com/cid/advance-article-abstract/doi/10.1093/cid/ciaa1622/5939856
2021 | Year | 01 | Month | 20 | Day |
Main results already published
2019 | Year | 09 | Month | 30 | Day |
2019 | Year | 09 | Month | 30 | Day |
2019 | Year | 10 | Month | 07 | Day |
2020 | Year | 01 | Month | 31 | Day |
N/A
2019 | Year | 09 | Month | 30 | Day |
2021 | Year | 01 | Month | 20 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000043498
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |